Related Experiment Video
Updated: Dec 5, 2025

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Oral Immunotherapy for Food Allergy-a US Regulatory Perspective
Kathleen Hise1,2, Ronald L Rabin3,4
1Division of Vaccines and Related Products Applications, US Food and Drug Administration, Silver Spring, MD, USA.
Abstract:
The recent approval of Palforzia for treatment of peanut allergy by the US Food and Drug Administration (USFDA) predicts that additional products for oral immunotherapy (OIT) are on the horizon. In this article, the authors review the legal framework by which the USFDA regulates products for OIT of food allergy and the clinical data that demonstrated that the safety and effectiveness profile of Palforzia supported approval and conclude with a discussion of oral food challenge (OFC) as a clinical endpoint to demonstrate safety and effectiveness of OIT products.
Related Concept Videos
Drug Regulation
Allergic Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drug Products: Biologics, Biosimilars and Interchangeables
Clinically Relevant Drug Product Specifications: Methods of Establishment
Preclinical Development: Overview

